16.95
price down icon8.26%   -1.525
after-market After Hours: 16.90 -0.045 -0.27%
loading
Scilex Holding Company stock is traded at $16.95, with a volume of 101.43K. It is down -8.26% in the last 24 hours and up +0.74% over the past month. Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$18.47
Open:
$18.51
24h Volume:
101.43K
Relative Volume:
0.42
Market Cap:
$117.86M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-13.14
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
-6.12%
1M Performance:
+0.74%
6M Performance:
+245.11%
1Y Performance:
-54.75%
1-Day Range:
Value
$16.80
$19.19
1-Week Range:
Value
$16.05
$21.00
52-Week Range:
Value
$3.60
$39.20

Scilex Holding Company Stock (SCLX) Company Profile

Name
Name
Scilex Holding Company
Name
Phone
(650) 516-4310
Name
Address
960 SAN ANTONIO ROAD, PALO ALTO
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCLX's Discussions on Twitter

Compare SCLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
SCLX
Scilex Holding Company
16.95 136.79M 46.74M -114.33M -21.04M -1.29
Drug Manufacturers - General icon
LLY
Lilly Eli Co
937.44 828.62B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
186.97 448.13B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
219.04 383.12B 59.64B 2.36B 18.24B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.57 240.81B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
85.78 209.46B 63.99B 19.05B 14.72B 7.5596

Scilex Holding Company Stock (SCLX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-27-25 Initiated D. Boral Capital Buy
Oct-16-24 Initiated Alliance Global Partners Buy
Jun-13-24 Initiated Rodman & Renshaw Buy
Oct-16-23 Initiated B. Riley Securities Buy
Oct-13-23 Initiated B. Riley Securities Buy
Oct-09-23 Initiated H.C. Wainwright Buy
View All

Scilex Holding Company Stock (SCLX) Latest News

pulisher
Nov 06, 2025

Datavault AI (NASDAQ: DVLT) Grants Exclusive Worldwide License to Scilex for AI-Driven Biotech Exchange Platform - Digital Journal

Nov 06, 2025
pulisher
Nov 06, 2025

Datavault AI Grants Scilex Exclusive License for Biotech Exchange Platform in Multi-Billion Dollar Deal - citybuzz -

Nov 06, 2025
pulisher
Nov 06, 2025

Datavault AI Grants Scilex Exclusive License for AI-Driven Biotech Exchange Platform - citybuzz -

Nov 06, 2025
pulisher
Nov 06, 2025

Scilex Holding Company (SCLX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 06, 2025
pulisher
Nov 06, 2025

Will Scilex Holding Company stock rally after Fed decisionsWeekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Will Scilex Holding Company stock remain a Wall Street favoriteGap Down & Verified Stock Trade Ideas - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Applying chart zones and confluence areas to Scilex Holding Company Equity WarrantEarnings Growth Report & Long-Term Growth Portfolio Plans - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Will Scilex Holding Company Equity Warrant stock maintain growth story2025 Market WrapUp & AI Powered Market Trend Analysis - fcp.pa.gov.br

Nov 06, 2025
pulisher
Nov 06, 2025

Market reaction to Scilex Holding Company’s recent news2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Signal strength of Scilex Holding Company Equity Warrant stock in tech scannersPortfolio Value Report & Expert Approved Momentum Ideas - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Comparing Scilex Holding Company in custom built stock radarsJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Why Scilex Holding Company Equity Warrant stock is favored by pension fundsMarket Trend Review & Community Driven Trade Alerts - fcp.pa.gov.br

Nov 06, 2025
pulisher
Nov 05, 2025

Will Scilex Holding Company stock maintain momentum in 2025Portfolio Risk Summary & High Return Trade Opportunity Guides - fcp.pa.gov.br

Nov 05, 2025
pulisher
Nov 05, 2025

How Scilex Holding Company Equity Warrant stock benefits from global expansionPortfolio Risk Summary & Technical Entry and Exit Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Can Scilex Holding Company Equity Warrant stock resist sector downturns2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

How to integrate Scilex Holding Company Equity Warrant into portfolio analysis toolsPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

What technical models suggest about Scilex Holding Company Equity Warrant’s comebackWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Datavault AI Enters Major Licensing Agreement with Scilex - TipRanks

Nov 05, 2025
pulisher
Nov 05, 2025

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information - The Globe and Mail

Nov 05, 2025
pulisher
Nov 05, 2025

Scilex Holding Company Stock Analysis and ForecastMarket Profile Overview & Exceptional Profit Ideas - earlytimes.in

Nov 05, 2025
pulisher
Nov 05, 2025

Using data models to predict Scilex Holding Company stock movementWeekly Profit Report & AI Powered Buy/Sell Recommendations - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Technical signs of recovery in Scilex Holding Company2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Will Scilex Holding Company Equity Warrant stock outperform tech sector in 2025Earnings Miss & Weekly Breakout Stock Alerts - newser.com

Nov 05, 2025
pulisher
Nov 04, 2025

Real time alert setup for Scilex Holding Company performanceJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Will Scilex Holding Company Equity Warrant stock outperform international peersPrice Action & Capital Efficiency Focused Ideas - fcp.pa.gov.br

Nov 04, 2025
pulisher
Nov 04, 2025

Scilex Holding Company (SCLX) Stock: Soars 9.43% on Breakthrough Biotech Licensing Deal - parameter.io

Nov 04, 2025
pulisher
Nov 04, 2025

Scilex Enters Exclusive License Agreement with Datavault AI - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI announces $10 mln worldwide exclusive license agreement with Scilex Holding Co - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI Inc. and Scilex Holding Company Announces Exclusive License Agreement - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI Inc. Announces a $10M Worldwide Exclusive - GlobeNewswire

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information - GlobeNewswire Inc.

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ: - openPR.com

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ: SCLX) with Exclusive License to Tokenize $2 Trillion in Biotech – Bonus Stocks Inside - Markets Financial Content

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI Inc. Grants Exclusive License to Scilex Holding Company for AI-Driven Biotech Exchange Platform - Quiver Quantitative

Nov 04, 2025
pulisher
Nov 04, 2025

Datavault AI (NASDAQ: DVLT) licenses to Scilex; $10M upfront, up to $2.55B - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI - The Manila Times

Nov 04, 2025
pulisher
Nov 04, 2025

Scilex (NASDAQ: SCLX) licenses Datavault AI to tokenize data; milestones up to $2.55B - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

Order flow analysis tools used on Scilex Holding CompanyAnalyst Downgrade & Weekly High Momentum Picks - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

Scilex Holding Company Announces the Sponsorship of Dream - GlobeNewswire

Nov 03, 2025
pulisher
Nov 03, 2025

Datavault AI Announces Record Date of Nov. 14, 2025, for Dream Bowl Draft Meme Coin Distribution to All Eligible Scilex and Datavault AI Shareholders - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

How to use a screener to detect Scilex Holding Company Equity Warrant breakouts2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Scilex Holding Company Equity Warrant stock maintain operating marginsQuarterly Trade Report & Free Weekly Watchlist of Top Performers - fcp.pa.gov.br

Nov 03, 2025
pulisher
Nov 03, 2025

Momentum divergence signals in Scilex Holding Company chartWeekly Risk Summary & Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025

Scilex Holding Company Stock (SCLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general SNY
$49.49
price up icon 1.00%
drug_manufacturers_general PFE
$24.85
price up icon 0.98%
$123.40
price up icon 0.67%
drug_manufacturers_general NVO
$46.51
price down icon 4.02%
$315.59
price down icon 1.33%
drug_manufacturers_general MRK
$85.78
price up icon 1.65%
Cap:     |  Volume (24h):